Wolf, Dieter A.,
Mitochondrial inhibition as a novel therapeutic approach in drug-resistant cancer [electronic resource] / Dieter A. Wolf. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (31 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Drug resistance in prostate cancer -- Role of androgen receptor in prostate cancer -- Difficulties in finding new prostate cancer drug targets -- Rational behind screening for p27 downregulators -- Potential for OXPHOS inhibitors in cancer therapy -- SMIP004: p27 downregulator and potential drug.
Access restricted to subscribers.
Mode of access: World Wide Web.
4347 Henry Stewart Talks
Antineoplastic agents.
Drug resistance in cancer cells.
Prostate--Cancer--Chemotherapy.
Antineoplastic Agents--pharmacology.
Antineoplastic Agents--therapeutic use.
Down-Regulation--drug effects.
Drug Resistance, Neoplasm.
Mitochondria--drug effects.
Mitochondria--metabolism.
Oxidative Phosphorylation--drug effects.
Prostatic Neoplasms--drug therapy.
Prostatic Neoplasms--metabolism.
Prostatic Neoplasms--pathology.
Receptors, Androgen.
S-Phase Kinase-Associated Proteins.
Mitochondrial inhibition as a novel therapeutic approach in drug-resistant cancer [electronic resource] / Dieter A. Wolf. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (31 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Drug resistance in prostate cancer -- Role of androgen receptor in prostate cancer -- Difficulties in finding new prostate cancer drug targets -- Rational behind screening for p27 downregulators -- Potential for OXPHOS inhibitors in cancer therapy -- SMIP004: p27 downregulator and potential drug.
Access restricted to subscribers.
Mode of access: World Wide Web.
4347 Henry Stewart Talks
Antineoplastic agents.
Drug resistance in cancer cells.
Prostate--Cancer--Chemotherapy.
Antineoplastic Agents--pharmacology.
Antineoplastic Agents--therapeutic use.
Down-Regulation--drug effects.
Drug Resistance, Neoplasm.
Mitochondria--drug effects.
Mitochondria--metabolism.
Oxidative Phosphorylation--drug effects.
Prostatic Neoplasms--drug therapy.
Prostatic Neoplasms--metabolism.
Prostatic Neoplasms--pathology.
Receptors, Androgen.
S-Phase Kinase-Associated Proteins.